Pulmonary Hypertension Associated with Interstitial Lung Disease
📧 Sign up to get email alerts when something new happens for Pulmonary Hypertension Associated with Interstitial Lung Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-19Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 3]
Phase 3 study evaluating seralutinib for pulmonary hypertension associated with interstitial lung disease is currently suspended, with updat…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: A Clinical Trial of NS-863 in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) [Phase 2]
This document provides an update on a Phase 2 trial of NS-863 in pulmonary hypertension associated with interstitial lung disease (PH-ILD). …
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: An Expanded Access Study to Assess Treprostinil Palmitil Inhalation Powder (TPIP) for Participants With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
An expanded access study evaluating Treprostinil Palmitil Inhalation Powder (TPIP) for patients with pulmonary arterial hypertension and pul…